Latest & greatest articles for beclomethasone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on beclomethasone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on beclomethasone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for beclomethasone

21. Beclomethasone at different doses for chronic asthma (review). (PubMed)

Beclomethasone at different doses for chronic asthma (review). Beclomethasone dipropionate (BDP) is available in a wide range of daily doses for the treatment of long-term asthma.To assess the evidence for a dose response relationship for BDP in the treatment of long-term asthma.We searched the Cochrane Airways Group trial register, Cochrane Controlled Trials Register (The Cochrane Library issue 1 1999) and references lists of articles. Authors and Glaxo Wellcome UK were contacted to identify

2001 Cochrane

22. Beclomethasone for asthma in children: effects on linear growth. (PubMed)

Beclomethasone for asthma in children: effects on linear growth. Inhaled steroids play a central role in the management of childhood asthma. There is concern about their side effects, especially on growth. However asthma may also cause growth retardation. Growth rates are not stable, so randomised controlled parallel group studies are needed to assess the impact of inhaled steroids on growth. This review is confine to one inhaled steroid, beclomethasone, that is known to have significant levels (...) of systemic absorption.To determine whether inhaled beclomethasone cause significant delay in the linear growth of children with asthma.The Cochrane Airways Group asthma register was searched. Bibliographies from included studies, and known reviews were searched for additional citations. Personal contact with colleagues and researchers working in the field of asthma were made to identify potentially relevant trials.Randomized, controlled trials comparing the effects of beclamethasone to non-steroidal

2000 Cochrane

23. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. (PubMed)

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. An inhaled glucocorticoid is currently the medication of choice for long-term control of persistent asthma in children. The role of long-acting beta2-adrenergic-receptor agonists, such as salmeterol, needs to be defined.We conducted a randomized, double-blind, placebo-controlled, parallel-group, one-year study of 241 children (mean [+/-SD] age (...) , 9.3+/-2.4 years) with clinically stable asthma and less than one month of prior glucocorticoid use. We compared inhaled beclomethasone dipropionate (200 microg twice daily) with salmeterol xinafoate (50 microg twice daily) and placebo (lactose). The primary outcome measure, airway responsiveness (as assessed with a methacholine challenge) was evaluated before treatment; after 3, 6, 9, and 12 months of treatment (12 and 36 hours after study medications had been withheld); and 2 weeks after the end

1997 NEJM

24. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. (PubMed)

Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Since beclomethasone dipropionate (BDP) is a very potent glucocorticoid and since small oral doses (1 mg) seem to be metabolised (possibly in the gut wall or liver) before they reach the systemic circulation, a study was conducted to find out whether patients with inflammatory bowel disease could be treated with enemas containing small

1982 Lancet

25. Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. (PubMed)

Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. A double-blind cross-over trial was carried out to compare the effect of identical placebo with that of salbutamol inhalers used 30 min before inhalation of 100 microgram of beclomethasone dipropionate (B.D.P.) in 18 chronic asthmatics over two consecutive 4-week periods. The salbutamol and B.D.P. combination resulted in a significant improvement in the peak expiratory flow-rate and F.E.V.1, significantly less use

1978 Lancet

26. [Beclomethasone aerosol in asthma therapy]. (PubMed)

[Beclomethasone aerosol in asthma therapy]. 4608500 1975 01 06 2013 11 21 0012-7183 90 18 1974 Duodecim; laaketieteellinen aikakauskirja Duodecim [Beclomethasone aerosol in asthma therapy]. 1228-34 Muittari A A Veneskoski T T fin Clinical Trial Comparative Study Controlled Clinical Trial English Abstract Journal Article Randomized Controlled Trial Beklometasoni paineaerosolina astman hoidossa Finland Duodecim 0373207 0012-7183 0 Aerosols 0 Anti-Inflammatory Agents 0 Placebos 9PHQ9Y1OLM (...) Prednisolone KGZ1SLC28Z Beclomethasone L628TT009W Isoproterenol QF8SVZ843E Albuterol WI4X0X7BPJ Hydrocortisone IM Administration, Topical Adult Aerosols Aged Albuterol therapeutic use Anti-Inflammatory Agents administration & dosage therapeutic use Asthma drug therapy Beclomethasone administration & dosage adverse effects therapeutic use Clinical Trials as Topic Drug Therapy, Combination Female Humans Hydrocortisone blood Isoproterenol therapeutic use Male Middle Aged Placebos Prednisolone 1974 1 1 1974 1

1975 Duodecim; laaketieteellinen aikakauskirja